Peripheral artery disease (PAD) is a major health concern affecting more than 200 million
people worldwide and studies have shown PAD to be a strong predictor of mortality,
morbidity, and disability. The management of PAD is multi‐tiered and advancements in
technology have given physicians more options for endovascular revascularization if
medical therapy does not result in substantial improvement. Many randomized controlled
trials have reported efficacy of various therapies including laser atherectomy, stent …

The first published arterial endovascular procedure was performed by Dr. Charles Dotter in
1964 in the superficial femoral artery (1). Since then, the femoropopliteal segment has
posed many challenges and opportunities for inventors, industry, physicians, and, most
importantly, patients. The evolution in techniques and technologies over the last decade has
led to an increase in endovascular procedures with a reduction in the rates of major
amputation (2). Many devices have been developed; some are currently in use, but others …